Evidence map›Paper›PMID 23665121›Full record

ArticleCell stem cell2013

Genome-wide chromatin interactions of the Nanog locus in pluripotency, differentiation, and reprogramming.

Effie Apostolou, Francesco Ferrari, Ryan M Walsh, Ori Bar-Nur, Matthias Stadtfeld, Sihem Cheloufi, Hannah T Stuart, Jose M Polo, Toshiro K Ohsumi, Mark L Borowsky and 3 more

Abstract read
In one paragraph

Article in Cell stem cell, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 132 papers.

0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

132 citing papers in PubMed, 216 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. TET3 protects theiScience · 2025
    Article
  7. Aberrant Enhancer Regulation, Phase Separation, and Autoimmune Diseases.Clinical reviews in allergy & immunology · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. PBI-05204, a supercritical CONeoplasia (New York, N.Y.) · 2024
    Article
  15. Article
  16. Article
  17. Cohesin controls X chromosome structure remodeling and X-reactivation during mouse iPSC-reprogramming.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  18. Article
  19. Article
  20. Manipulating complex chromatin folding via CRISPR-guided bioorthogonal chemistry.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article

72 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Effie ApostolouMassachusetts General Hospital Cancer Center and Center for Regenerative Medicine, 185 Cambridge Street, Boston, MA 02114, USA.
Francesco Ferrari
Ryan M Walsh
Ori Bar-Nur
Matthias Stadtfeld
Sihem Cheloufi
Hannah T Stuart
Jose M Polo
Toshiro K Ohsumi
Mark L Borowsky
Peter V Kharchenko
Peter J Park
Konrad Hochedlinger
Harvard University · USBoston Children's Hospital · USHarvard Stem Cell Institute · USMassachusetts General Hospital · USHoward Hughes Medical Institute · US

Funding

Transcription Factor Induced ReprogrammingR01HD058013 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI HOCHEDLINGER, KONRAD · 2010 to 2019
$4.4M
Comparative phenotypic, functional, and molecular analysis of ESC and iPSCRC2HL102815 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI CHURCH, GEORGE M, COLLINS, JAMES J · 2009 to 2010
$3.4M
Reprogramming of somatic cells by defined factorsDP2OD003266 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI HOCHEDLINGER, KONRAD · 2007 to 2007
$2.6M
Age-associated chromatin changes in hematopoiesisK25AG037596 · NIA · HARVARD MEDICAL SCHOOL · PI KHARCHENKO, PETER V · 2010 to 2014
$749k
NHLBI NIH HHS RC2 HL102815NHLBI NIH HHS RC2HL102815NIA NIH HHS K25 AG037596NIA NIH HHS K25AG037596NICHD NIH HHS R01 HD058013NICHD NIH HHS R01HD058013NIH HHS DP2 OD003266NIH HHS DP2OD003266
6 · The paper itself

Abstract

The chromatin state of pluripotency genes has been studied extensively in embryonic stem cells (ESCs) and differentiated cells, but their potential interactions with other parts of the genome remain largely unexplored. Here, we identified a genome-wide, pluripotency-specific interaction network around the Nanog promoter by adapting circular chromosome conformation capture sequencing. This network was rearranged during differentiation and restored in induced pluripotent stem cells. A large fraction of Nanog-interacting loci were bound by Mediator or cohesin in pluripotent cells. Depletion of these proteins from ESCs resulted in a disruption of contacts and the acquisition of a differentiation-specific interaction pattern prior to obvious transcriptional and phenotypic changes. Similarly, the establishment of Nanog interactions during reprogramming often preceded transcriptional upregulation of associated genes, suggesting a causative link. Our results document a complex, pluripotency-specific chromatin "interactome" for Nanog and suggest a functional role for long-range genomic interactions in the maintenance and induction of pluripotency.

Indexed as

AnimalsCellular ReprogrammingChromatinGenomeHomeodomain ProteinsHumansMiceNanog Homeobox ProteinPluripotent Stem CellsChromatinHomeodomain ProteinsNanog Homeobox ProteinNANOG protein, humanNanog protein, mouse

Identifiers

PMID23665121
PMCPMC3725985
OpenAlexW2103428287

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.